webmaster-prism

About webmaster-prism

This author has not yet filled in any details.
So far webmaster-prism has created 72 blog entries.

How a Trade Commercialization Team Makes Licensing Easier

2020-02-26T15:00:34+00:00June 26th, 2018|Categories: Blog|Tags: , , |

Licensing is a required step in the pharma industry, and unfortunately, it can be incredibly complicated. The consequences for not carrying the correct license can range from fines to an immediate stop in sales to felony charges – and that’s just the beginning. We covered the basics in an earlier post, but while a general knowledge of the ins and outs is helpful, you’ll need more than an overview [...]

Two Labs Hires Anita Dopkosky as Vice President of Specialty Pharmacy

2020-03-02T20:07:37+00:00May 11th, 2018|Categories: News|Tags: |

Two Labs, an industry-leading pharma and life science services company, announced at Asembia’s 2018 Specialty Pharmacy Summit that Anita Dopkosky, a pharmaceutical industry executive, has joined the Commercialization team as Vice President of Specialty Pharmacy. Dopkosky will be responsible for helping pharma and biotech manufacturers develop efficient, cost-effective distribution models to serve patients, caregivers and prescribing physicians. In addition, she will work with trading partners to identify areas of collaboration [...]

Two Labs Hires Anita Dopkosky as Vice President of Specialty Pharmacy

2020-02-26T15:01:24+00:00May 10th, 2018|Categories: Blog|Tags: , |

At Two Labs, we value partnership. Our clients view us as an extended part of their team, not a vendor. And as the pharma market continues to evolve, we are excited for the growth we can experience by incorporating additional insightful team members. During Asembia’s 2018 Specialty Pharmacy Summit earlier this month, Two Labs welcomed Anita Dopkosky, a pharmaceutical industry executive, as Vice President of Specialty Pharmacy. She is [...]

Two Labs Acquires MKO Global Partners

2020-02-26T15:08:32+00:00February 8th, 2018|Categories: Blog|Tags: , , |

At Two Labs, we’re committed to staying at the forefront of the evolving healthcare market -- and to support our growth goals, we believe it’s invaluable to add insightful team members who have their own valuable perspectives. Today, we are pleased to share that as of February 2, 2018, Two Labs has acquired MKO Global Partners (MKO), a strategic global life sciences consulting firm focused on payer strategy, [...]

Two Labs Acquires MKO Global Partners

2020-03-02T20:07:32+00:00February 8th, 2018|Categories: News|Tags: |

Company expands presence in the pharma consulting space with the addition of pricing and payer strategy services COLUMBUS, Ohio (February 8, 2018) - Two Labs, an industry-leading pharma and life science services company, today announced that it has acquired MKO Global Partners (MKO), a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets. Two Labs’ mission is to improve [...]

Excellere Partners Announces Its Investment in Two Labs Marketing

2020-03-02T20:07:23+00:00January 31st, 2018|Categories: News|Tags: |

Denver, CO, January 31, 2017 - Excellere Partners, a Denver-based private equity firm focused on partnering with entrepreneurs and management teams, announced today that it has made a strategic investment in Two Labs Marketing, a leading provider of product commercialization solutions to pharmaceutical manufacturers, offering strategic consulting and implementation services throughout the full product lifecycle.  The Two Labs Marketing investment represents the tenth platform investment in Excellere Capital Fund [...]

How DSCSA Changes the Licensing Landscape for Third-Party Logistics

2020-02-26T15:10:39+00:00January 10th, 2018|Categories: Blog|Tags: , , , |

The Drug Supply Chain Security Act (DSCSA), passed in November 2013, has become a buzzword in the pharma industry in the past few years, and will continue to be until the completion of the implementation in 2023.  DSCSA describes creating an electronic, inter operable system that stores transaction information and history of a drug from the time of manufacture to when it is dispensed to a patient. The big license earthquake [...]

The Basics of Licensing: In & Out, Drug, & Facility

2020-02-26T15:17:42+00:00January 5th, 2018|Categories: Blog|Tags: , |

When you conduct a quick online search using the following phrases, a vast array of answers will cross your screen: "License a Drug or Facility" "Pharma Licensing" "How to start my own Pharma Company" The results of these searches tend to center around licensing: in-licensing, out-licensing, drug licensing, and facility licensing. How does all of this relate to launching a drug? Here are the basics: [...]

3 Entities That Can Change Your State Licensing Strategy

2020-02-26T15:18:25+00:00November 9th, 2017|Categories: Blog|Tags: , |

In the Pharmaceutical industry, licensing is never a static process. There are many changes that can alter your licensing strategy: 1. Your Company This one is pretty obvious. There are a number of different business changes that could direct the strategy of your licensing, or the maintenance of your state licenses. Some of the most common occurrences are: a change of business entity (i.e. LLC to INC), a change of [...]

Consequences Pharmaceutical Companies Can Face for not Carrying the Correct State License and Being Noncompliant

2020-02-26T15:19:13+00:00October 20th, 2017|Categories: Blog|Tags: , |

Anyone who is engaged in manufacturing, preparing, propagating, compounding, processing, packaging, marketing, selling, shipping, repackaging, or labeling a prescription drug, or wholesale distribution of a prescription drug...must obtain a license/permit in certain states to be in compliance. "But I didn't know!" This is a response that is never accepted by a government agency for a pharmaceutical company's inaction to remain in compliance with state licensing. In analyzing the costs [...]

Contact Info

110 Riverbend Avenue, Suite 100, Powell, OH 43065

Phone: 614.389.4004

Fax: 866.259.4324

Recent News